Bayesian estimation of HIV acquisition dates for prevention trials
Raabya Rossenkhan(Fred Hutch Cancer Center), Paul T. Edlefsen(Fred Hutch Cancer Center), Michal Juraska(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Yunda Huang(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Kamini Gounder(Centre for the AIDS Programme of Research in South Africa), Anna Yssel(University of Cape Town), Bruce D. Walker(Howard Hughes Medical Institute), Bette Korber(Los Alamos National Laboratory), Jan Phillipus Lourens Labuschagne(South African Medical Research Council), Dylan H. Westfall(University of Washington), Shelley N. Facente(Virginia Department of Health), Daniel Muema(Africa Health Research Institute), Allan C. deCamp(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Craig A. Magaret(Fred Hutch Cancer Center), Wenjie Deng(University of Washington), David Matten(University of Cape Town), Thumbi Ndung’u(Africa Health Research Institute), Carolyn Williamson(National Health Laboratory Service), Eduard Grebe(University of California, San Francisco), Ewelina Kosmider(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Tanmoy Bhattacharya(Los Alamos National Laboratory), Leigh Anne Eller, Fred Sawe(Henry M. Jackson Foundation), Erika Rudnicki(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lawrence Corey(Fred Hutch Cancer Center), Bryan T. Mayer(Fred Hutch Cancer Center), Morgane Rolland(Henry M. Jackson Foundation), Sorachai Nitayaphan(Royal Thai Army), Merlin L. Robb(University of Maryland, Baltimore), Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lindsay N. Carpp(Fred Hutch Cancer Center), Elena E. Giorgi(Fred Hutch Cancer Center), Daniel B. Reeves(Fred Hutch Cancer Center), Krista L. Dong(Harvard University), M. Busch(University of California, San Francisco), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), James I. Mullins(University of Washington), Kevin P. Delaney(National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention), Danica Shao(Fred Hutch Cancer Center), James P. Ludwig
Cited by 3
Related Papers
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
|New England Journal of Medicine|2009|3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k